ResMed Inc. Stock Boerse Muenchen
Stocks
RMEA
AU000000RMD6
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.40 EUR | +1.66% |
|
+1.12% | -12.14% |
| 08-07 | ResMed shares tumble as weak 2027 sales forecast eclipses quarterly profit beat | RE |
| 08-07 | Jefferies Adjusts Price Target on ResMed to $220 From $225 | MT |
| Market Cap | 31.74B 27.48B 25.68B 23.47B 44.23B 3,027B 44.93B 301B 118B 1,514B 119B 117B 5,044B | P/E 2026 |
18.7x | P/E 2027 * | 19.1x |
|---|---|---|---|---|---|
| Enterprise Value | 30.86B 26.72B 24.97B 22.83B 43.01B 2,944B 43.69B 293B 115B 1,473B 116B 113B 4,905B | EV / Sales 2026 |
4.84x | EV / Sales 2027 * | 5.29x |
| Free-Float |
37.81% | Yield 2026 |
1.26% | Yield 2027 * | 1.21% |
Last Transcript: ResMed Inc.
| 1 week | +0.55% | ||
| Current month | +2.79% | ||
| 1 month | +0.55% | ||
| 3 months | +6.98% | ||
| 6 months | -18.58% | ||
| Current year | -10.68% |
| 1 week | 18.1 |  | 19.1 |
| 1 month | 17.2 | | 19.1 |
| 3 years | 13.1 | | 24.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 2013-02-28 |
Aaron Bloomer
DFI | Director of Finance/CFO | 40 | 2026-05-03 |
Jim Ellis
CMP | Compliance Officer | - | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 2004-12-31 |
Mick Farrell
CHM | Chairman | 53 | 2023-01-24 |
Peter Farrell
CHM | Chairman | 83 | 1989-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.66% | +1.12% | -22.69% | +12.20% | 30.57B | |
| +0.96% | +4.47% | +30.16% | +9.58% | 220B | |
| +2.25% | +6.01% | +4.39% | -18.65% | 144B | |
| +3.85% | +4.79% | -16.32% | +29.12% | 134B | |
| +2.33% | +4.19% | -51.08% | -0.79% | 71.46B | |
| +2.57% | +3.61% | +17.46% | +17.57% | 51.71B | |
| -0.86% | +0.15% | -15.64% | -18.16% | 50.84B | |
| +1.88% | +6.38% | +29.75% | +16.51% | 41.23B | |
| +1.21% | +9.88% | +46.43% | +42.33% | 39.95B | |
| +1.63% | +4.60% | +1.31% | +0.89% | 32.42B | |
| Average | +1.76% | +4.56% | +2.38% | +9.06% | 87.22B | |
| Weighted average by Cap. | +1.89% | +5.45% | +4.86% | +7.38% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 5.65B 4.89B 4.57B 4.18B 7.87B 539B 7.99B 53.6B 21.03B 270B 21.21B 20.75B 898B | 5.81B 5.03B 4.7B 4.3B 8.1B 554B 8.23B 55.16B 21.64B 277B 21.83B 21.35B 924B |
| Net income | 1.54B 1.33B 1.25B 1.14B 2.15B 147B 2.18B 14.62B 5.74B 73.5B 5.78B 5.66B 245B | 1.63B 1.41B 1.32B 1.21B 2.28B 156B 2.31B 15.51B 6.08B 77.97B 6.14B 6B 260B |
| Net Debt | -877M -759M -710M -649M -1.22B -83.65B -1.24B -8.32B -3.27B -41.85B -3.29B -3.22B -139B | -966M -836M -781M -714M -1.35B -92.09B -1.37B -9.16B -3.59B -46.07B -3.63B -3.55B -153B |
| Date | Price | Change |
|---|---|---|
| 26-08-10 | €18.40 | +1.66% |
| 26-08-07 | €18.10 | -5.24% |
| 26-08-06 | €19.10 | +0.53% |
| 26-08-05 | €19.00 | +0.53% |
| 26-08-04 | €18.90 | +3.28% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
- RMEA Stock
Select your edition
All financial news and data tailored to specific country editions
